Abzena takes modular approach to biologics suites
This expansion has been driven by an increase in customer demand for commercial-scale 2000L single-use bioreactors across a wide range of therapeutic areas
Breaking News
Samsung Bioepis opens Korea HQ for biologics
The building was completed in December 2020
Thermo Fisher acquires viral vector manufacturing business from Novasep
The business will be part of the pharma services business within the laboratory products and services segment
Nanoform and Herantis partner
The companies will look for opportunities to enhance BBB penetration of CDNF and xCDNF molecules
Time to rethink your biopharmaceutical workflow?
Udo Losehand, Head of Global Technical Developers, Roquette, explains everything you need to know about single-use ...
WHP completes viral vector manufacturing centre for Oxford Biomedica
The centre is being used for the worldwide manufacture and distribution of the COVID-19 vaccine by AstraZeneca
EVerZom raises $1.3m to industrialise exosome biomanufacturing platform
This funding will speed up the platform development and scale-up, with the objective to allow routine clinical grade ...
The increasing power of single-cell omics: changing the future of medicine
Advances in the single-cell genomic analysis of cells and tissues, including the required computational methods, have ...
Watson-Marlow to open ISO 14644-1 Class 7 cleanroom
The facility at the site in Cork is currently in development and will be validated to ISO 9001 Quality Management ...
Thermo Fisher Scientific and Innoforce join forces
The two companies have partnered to establish a biologics and sterile drug manufacturing facility in China
The promise, challenge and evolution of cell and gene therapy
Cell and gene therapy treatments offer the hope of a cure for diseases that would otherwise result in a lifetime of ...
Immunotherapy: antibody drug conjugates from a small molecule perspective
Immunotherapies such as ADCs deliver a more targeted treatment against cancer that improves the quality of life for the ...
The industrial production of cell and gene therapies: part II
Dr Andrea Traube, Director of Market Development, Pharma, at OPTIMA pharma, and Dena Flamm, Business Development ...
VMIC chooses BES to help with fast-tracked vaccine facility
Boulting has been chosen to fit out a new facility for the not for profit organisation established to provide the UK's ...
Scenic Biotech enters into genetic modifier collaboration with Genentech
Multi-year strategic collaboration in target discovery and therapeutic development based on Scenic Biotech’s disease ...
In Brief
Most Popular in Biotechnology
Featured Companies
Reports
